StockData
Janux Therapeutics, Inc. logo

Janux Therapeutics, Inc. (JANX) stock

JANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3037% below fair value
$10.71−0.21 (-1.92%)

Close on Nov 17, 2026Market cap $654.78MP/E –Yield –

Janux Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Janux Therapeutics's market cap was $756.76M on Nov 11, 2026, against $2.05B a year earlier. Over the last 5 years it ranged from $268.79M to $2.82B, with a median of $867.72M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$756.76M-8.8%
2025Dec 31, 2025$829.71M-70.4%
2024Dec 31, 2024$2.80B+465.9%
2023Dec 29, 2023$495.20M-9.5%
2022Dec 30, 2022$547.22M-32.6%
2021Dec 31, 2021$812.32M–

More Janux Therapeutics figures

See a number that looks wrong?